Environmental Toxicology
*Corresponding author: Mohammad Ali Eghbal, Tel: +98 41 33372250-1, Email: [email protected], §: These authors contributed equally ©2015 The Authors. This is an Open Access article distributed under the terms of the Creative Commons Attribution (CC BY), which permits unrestricted use, distribution, and reproduction in any medium, as long as the original authors and source are cited. No permission is required from the authors or the publishers.
Adv Pharm Bull, 2015, 5(4), 447-454 doi: 10.15171/apb.2015.061
http://apb.tbzmed.ac.ir
Advanced
Pharmaceutical
Bulletin
A Review of Molecular Mechanisms Involved in Toxicity of
Nanoparticles
Javad Khalili Fard1,2,3,4§, Samira Jafari4,5§, Mohammad Ali Eghbal2,3*
1 Drug Applied Research Center, Tabriz University of Medical Sciences, Tabriz, Iran. 2 Biotechnology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran. 3 Department of Pharmacology and Toxicology, Faculty of Pharmacy, Tabriz University of Medical Science, Tabriz, Iran. 4 Student Research Committee, Tabriz University of Medical Science, Tabriz, Iran. 5 Department of Pharmaceutical Nanotechnology, Faculty of Pharmacy, Tabriz University of Medical Science, Tabriz, Iran.
Introduction
Nanotechnology advancement in medical sciences led to
the design and synthesis of nanostructures for biomedical
applications. Due to unique properties of NPs such as
small size (1-100 nm in diameter) and the greater surface
area to volume ratio as well as different electronic,
magnetic, optical and mechanical properties and also
particle shape, these particles hold great interests in the
various fields.1-6
It may seem that NPs do not have toxic effects.
However, the greater surface area to volume ratio of
these particles causes their higher chemical reactivity and
results in increased production of reactive oxygen
species (ROS). Indeed, the NPs surface area is a key
factor in their intrinsic toxicity because of the interaction
of their surfaces with biological system.7-10
ROS formation is one of the mechanisms of NPs toxicity
which could cause oxidative stress, inflammation and
consequent damages to the proteins, cell membrane and
DNA. Therefore, assessment of nanoparticles toxicity is
necessary in biomedical applications including drug
delivery systems, gene delivery and therapeutic
applications.11-14
Prooxidants are chemicals that induce oxidative stress
through either creating reactive oxygen species or
inhibiting antioxidants. NPs react with cells and induce
their prooxidant effects via intracellular ROS generation
involving mitochondrial respiration and activation of
NADPH-dependent enzyme systems.15-17
NPs can activate the cellular redox system specifically in
the lungs where the immune cells including alveolar
macrophages (AM) and neutrophils act as direct ROS
inducers. Professional phagocytic cells of the immune
system including neutrophils and AMs induce
remarkable ROS upon internalization of NPs via the
NADPH oxidase enzyme system.16,18
In this review, we have focused on introducing in vitro
toxicity assays for cytotoxicity assessment of
nanoparticles. We have also reviewed toxic effect of
several nanoparticles such as carbon nanotubes, titanium
dioxide NPs, quantum dots, gold NPs and silver NPs.
Cytotoxicity assays of nanoparticles
Cytotoxicity assays are classified as in vivo and in vitro
tests. In vivo toxicity assays (cell-based assay) are time-
consuming and expensive and involve ethical issues but
in vitro toxicity tests (cell cultured-based assay) are
faster, convenient, less expensive and devoid of any
ethical issues. Due to these advantages, in vitro assays
are the first choice for toxicity assessment of most
nanomaterials.19
In vitro methods include approaches for assessment of
integrity of the cell membrane and the metabolic activity
Article info
Article History:
Received: 4 February 2015 Revised: 20 August 2015
Accepted: 25 August 2015
ePublished: 30 November 2015
Keywords:
Oxidative stress
Reactivity oxygen species
Cytotoxicity
Nanoparticles
Mechanism
Prooxidant effects
Abstract In recent decades, the use of nanomaterials has received much attention in industrial and
medical fields. However, some reports have mentioned adverse effects of these materials on
the biological systems and cellular components. There are several major mechanisms for
cytotoxicity of nanoparticles (NPs) such as physicochemical properties, contamination with
toxic element, fibrous structure, high surface charge and radical species generation. In this
review, a brief key mechanisms involved in toxic effect of NPs are given, followed by the in
vitro toxicity assays of NPs and prooxidant effects of several NPs such as carbon nanotubes,
titanium dioxide NPs, quantum dots, gold NPs and silver NPs.
Review Article
448 | Advanced Pharmaceutical Bulletin, 2015, 5(4), 447-454
Khalili fard et al.
of viable cells. Evaluation of cell membrane integrity is
one of the most common approaches to measure cell
viability. It is based on the leakage of substances such as
lactate dehydrogenase (LDH) that normally reside inside
cells to the external environment and the measurement of
LDH activity in the extracellular media. Alternatively,
membrane integrity can be determined by penetration of
dyes such as trypan blue and neutral red into the
damaged cells and staining intracellular components.
These dyes cannot enter living cells. Metabolic activity
of viable cells could be determined through colorimetric
assays, such as the MTT and MTS assays.20-23
Bioluminescent methods including methods using
luciferase, which catalyzes the formation of light from
adenosine triphosphate (ATP) are also commonly used as
cell viability assays in which the number of surviving
cells is determined by measuring the uptake and
accumulation of neutral red dye and trypan blue after
exposure to the toxicant.24-26 Among in vitro methods,
LDH, MTT and MTS assay are most widely used for
assessment of nanoparticles cytotoxicity (Table 1).27
LDH test
In general, LDH test is a colorimetric assay that
quantitatively measures LDH, a marker of cell membrane
integrity, released from damaged cells into the culture
media. This assay is a fast, simple and reliable method for
determining cellular toxicity.28
MTT assay
MTT assay is another candidate assay for measurement
of cytotoxicity of NPs. 3-(4,5-Dimethylthiazol-2-yl)-2,5-
Diphenyltetrazolium Bromide, (MTT), is a yellow
substance which reduces to purple insoluble formazan
crystals by mitochondrial succinate dehydrogenases in
viable cells. This method is directly related to the
number of viable cells.29
MTS assay
In the MTS (3-(4,5-dimethylthiazol-2-yl)-5-(3-
carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-
tetrazolium) assay, viable cells will convert tetrazolium
salt into a colored soluble formazan product by
mitochondrial dehydrogenase enzymes. Indeed, in MTS
assay, similar to MTT assay, a colorimetric product is
formed. The formazan produced is directly proportional
to the number of living cells in the culture.30
Toxicity mechanisms of nanoparticles
Physicochemical reactivity of NPs lead to the formation
of free radicals or ROS including superoxide radical
anions and hydroxyl radicals direct or indirect through
activation of oxidative enzymatic pathways result in
oxidative stress (Figure 1).31-36 In general, there are
several sources for oxidative stress:
Oxidant-generating properties of particles themselves
as well as their ability to stimulate generation of ROS
as a part of cellular response to nanoparticles
Transition metal-based nanoparticles or transition
metal contaminants used as catalysts during the
production of non-metal nanoparticles.
Relatively stable free radical intermediates present on
reactive surfaces of particles.
Redox active groups resulting from functionalization
of nanoparticles
The following briefly introduces cytotoxicity of some of
nanoparticles such as carbon nanotubes, titanium dioxide
NPs, quantum dots, gold NPs and silver NPs.
Figure 1. ROS generation induced by NPs and their cytotoxicity mechanism.
Cytotoxicity of carbon nanotubes
Carbon nanotubes (CNTs), fiber shaped nanostructures,
are allotropes of carbon which are categorized as single
wall carbon nanotubes (SWCNT) and multi wall carbon
nanotubes (MWCNT). In addition to industrial uses,
carbon nanotubes, due to their unique electrical, physical
and thermal qualities hold great interest in biomedical
applications.37-39
Numerous reports have shown that CNT could induce
the ROS generation in
multitudes of cell lines and activation of ROS-associated
intracellular signaling pathways in a dose-dependent
manner such as mitogen activated protein kinase
(MAPK), activator protein-1 (AP-1) and nuclear factor
kappa-light-chain-enhancer of activated B cells (NF-κB)
in mesothelial cells.40-43
It has been reported that MWCNT are able to stimulate
the release of the cytokines, IL-1β, TNF-α, IL-6 and IL-8
from mesothelial cells and macrophages. Murphy et al.
demonstrated that direct exposure to MWCNT causes to
length-dependent cytokine release from macrophages but
not mesothelial cells. However, treatment of the
mesothelial cells with conditioned medium from CNT-
treated macrophages led to increased secretion of
cytokines. In another study, MWCNT were revealed to
trigger the macrophages to produce TGF-β1 and platelet-
derived growth factor (PDGF) that promoted the
| 449
Mechanisms of Nanoparticle Toxicity
Advanced Pharmaceutical Bulletin, 2015, 5(4), 447-454
transformation of lung fibroblasts to myofibroblasts, a
major factor in development of fibrosis.44
Cytotoxicity of TiO2 nanoparticles
Widespread applications of titanium dioxide
nanoparticles (TiO2 NPs) in consumer products including
cosmetic, paints, pharmaceutical preparations, food
additives and so on is a result of their ability to confer
opacity and whiteness.45,46 In recent years, the
photocatalytic killing effect of TiO2 NPs on cancerous
cells has received great attention.47-49
The potential mechanism of cytotoxicity induced by
these non-soluble metal oxide NPs are still controversial.
In some literature, these NPs are even considered as a
natural nanomaterial.50 Conversely, some reports have
pointed out the potential toxicity of TiO2 nanoparticles,
including their ability to induce oxidative stress,
genotoxicity and immunotoxicity.51,52 However, the
mechanisms of these toxic effects are still blurred but
cytotoxicity evaluation of these metal oxide NPs is
important for in vivo and in vitro studies. Despite other
NPs such as ZnO, quantum dots and so, TiO2 NPs do not
release toxic ions hence toxicity of these particles could
be attributed to the size-dependent interaction between
nanoparticles and intracellular biomolecules adsorbed
onto nanoparticles.53-55 These interactions result in
generation of ROS, mitochondrial depolarization, plasma
membrane leakage, intracellular calcium influx and
cytokine release.56-59
In a study, Xiong et al. investigated size influence of
TiO2 NPs on their phototoxicity. Results showed that
there was a converse relationship between phototoxicity
and the size of these particles; as, the mortality of the
cells treated with 10 nm TiO2 NPs after photoactivation
by UV light was significantly higher than that of the cells
treated with larger particles (20 and 100 nm particles).
Furthermore, cytotoxicity of non-photoacivated 10, 20
and 100 nm NPs was not inconsiderable for cells treated
with them. In addition, the treated cells with 10 nm
photoactivated particles demonstrated a higher
generation of mitochondrial superoxide in comparison to
20 and 100 nm particles.
Indeed, the higher cytotoxicity induced by smaller
particles is related to their higher surface area and hence
contain a larger number of surface-exposed TiO2
molecules. Phototoxicity of these NPs could be
decreased via surface coating with chitosan or PEMA
because of the prevention of biomolecule adsorption and
hydroxyl radicals (.OH) production in the
photoactivation process.54
In another study, size-dependent toxicity of both TiO2
and PLGA was investigated. Findings revealed that
biomedically used PLGA nanoparticles did not show
strong cytotoxic effect in comparison to TiO2
nanoparticles. However, the smaller PLGA nanoparticles
have the potential to trigger the release of TNF-α. 200
nm PLGA nanoparticles could not trigger any negative
response from cells. Higher cytotoxic effect was
observed in cells treated with TiO2 nanoparticles,
especially at concentrations higher than 100μg/ml. The
size-dependent cytotoxicity of both PLGA and TiO2
nanoparticles could be attributed to the smaller size and
larger specific surface area and thus exposure of more
molecules on the surface that led to the adsorption of
more biomolecules such as proteins in the environment.60
Cytotoxicity of quantum dots
Quantum dots (QDs), colloidal semiconductor
nanoparticles, are a promising type of NPs which possess
exceptional optical properties including high fluorescent
quantum yield, broad absorption, narrow emission and
high photostability. These properties make QDs an
attractive candidate for in vivo imaging instead of
fluorescent dyes.61
Similar to other NPs, cytotoxicity of QDs depends on
parameters including size, shape, concentration, charge,
redox activity, surface coatings and mechanical stability of
these particles. Toxicity of uncoated core CdSe or CdTe-
QDs have been investigated in some literature. Two major
mechanisms are involved in the toxicity effects of these
inorganic nanoparticles are as follows:62-65
1) Cd+2 ions existing in QDs structure:
These toxic metal ions cause toxic effects through
several routes such as interference with DNA repair
and substitution for physiologic Zn. Cd+2 ions
increase oxidative stress but they cannot directly
generate free radicals.
2) Free radical formation:
QDs of CdSe and CdTe are highly reactive, thus,
photoactivation of these QDs via visible or UV light
leads to their oxidation. Indeed, a photon of light
could excite the QD and consequently generates an
excited electron that transfers to molecular oxygen,
forming singlet oxygen. Reaction of singlet oxygen
with water/other biological molecules results in
production of free radicals.
Kauffer et al. recently demonstrated that variation in core
compositions and surface chemistries of QDs, CdSe QDs
vs. CdS QDs, lead to their different cytotoxicity. The
former produced •OH radicals immediately after light
activation, while the latter required extensive irradiation
to generate an equivalent amount of radicals. Therefore,
the toxicity observed for CdSe QDs could be directly
related to •OH radicals produced. Indeed, cytotoxicity of
colloidal NPs can be controlled and relieved by choosing
appropriate materials for QD core and suitable irradiation
condition.66
Cytotoxicity of gold nanoparticles
Gold nanoparticles (GNPs), are one of the promising
inorganic (NPs) that have attracted scientific and
technological interests due to their ease of synthesis,
chemical stability and excellent optical properties.67-69
These unique properties of GNPs, make them appealing
tools for cancer diagnosis and treatment.70-72
Most of in vitro studies have indicated that these NPs are
nontoxic for cells. Evaluation of GNPs cytotoxicity is
essential because of broad spectrum application of GNPs
450 | Advanced Pharmaceutical Bulletin, 2015, 5(4), 447-454
Khalili fard et al.
in biomedical sciences. In the most of literature
investigations have demonstrated that these inorganic
nanoparticles are nontoxic. Cytotoxicity of GNPs
depends on their size, shape and surrounding ligands.73,74
Anisotropic GNPs have more potential oxidation than the
isotropic ones due to their highly exposed surface areas
and defects. Also, in some literature investigations
exhibited that spherical GNPs are suitable for biomedical
application.75-77
Recently, the cytotoxicity effects of 5 and/or 15 nm
GNPs 5 and 15 nm in vitro on Balb/3T3 mouse
fibroblasts have been investigated. In order to understand
the observed differences in cytotoxicity of two sizes of
GNPs, Gioria et al. examined the uptake and the
intracellular distribution of the NPs. The results indicated
cytotoxicity effects only for the cells treated with 5 nm
GNPs but no toxicity was revealed on Balb/3T3 for 15
nm GNPs. This observation is due to high number of 5
nm GNPs taken-up by cells in comparison to the larger
particles (15 nm particles).78
Cytotoxicity of silver nanoparticles
Antimicrobial properties of silver nanoparticles (AgNPs)
cause to the use of these NPs in a broad spectrum of
consumer products including cosmetics, electronics,
household appliances, textiles, and food products.79,80 In
the recent decade, AgNPs have been used in medical
fields such as drug delivery, designing biosensors, and
imaging contrast agents etc.81-83 Thus, toxicity assay is an
important factor to be considered in their application for
biomedical purposes. Cytotoxicity of these NPs is related
to comfortable oxidation AgNPs to Ag+ ions which are
very toxic for biological systems and cellular
components.84-87
Compton and coworkers in a study showed that AgNPs
in aqueous system are more toxic compared to the bulk
Ag is more toxic due to the presence of dissolved
oxygen, its reduction on NPs and then the release of
H2O2 from AgNPs. Also, results demonstrated that ROS
generation from nanoparticulated Ag are greater than that
of macro (bulk) silver.88
Recently, in a report the size- and coating-dependent
toxicity of thoroughly characterized AgNPs was
investigated following exposure to human lung cells. The
results revealed that only the cytotoxicity of the 10 nm
particles was independent of surface coating. In contrast,
all AgNPs tested caused an increase in overall DNA
damage after 24 h which suggests independent
mechanisms for the cytotoxicity and DNA damage.
However, there was no increased production of
intracellular ROS; therefore, the toxicity observed was
related to the rate of intracellular Ag release. Interaction
with thiol and amino groups of biomolecules and
appearance of the toxicity effect on cellular components
were a result of sliver release. Thus, AgNPs with higher
Ag release are more toxic.89
Table 1. Some in vitro assays with type of NPs and cell types.
Assay Type of NPs Type of cells (system) References
MTT assay QDs Human embryonic kidney cells 90
TiO2 Human erythrocyte/ lymphocyte cells 59
Natural red TiO2 NPs Zebrafish embryos 91
LDH test TiO2 NPs Human kidney cells
92 CNTs human pneumocytes cells
MTS assay Ag NPs mouse embryonic fibroblasts 93
Gold NPs Mammalian cells 94
Trypan blue Gold NPs mouse fibroblast 78
TiO2 NPs human lung epithelial cells 95
Conclusion
Despite the wide spread applications of nano-sized
materials in various sciences areas, there are numerous
reports about side effects of these materials on biological
systems and cellular compartments. In addition to
physicochemical properties, the production of toxic ions,
fibrous structure, high surface charge and generation of
radical species result in cytotoxicity by NPs including
carbon nanotubes, titanium dioxide NPs, quantum dots,
gold NPs and silver NPs. Both in vivo and in vitro assays
are used for toxicity assessment of NPs. In vitro assays
have received more attentions compared to in vivo
assays due to being faster, convenient, less expensive,
and devoid lacking any ethical issues.
Ethical Issues
Not applicable.
Conflict of Interest
The authors declare that they have no conflict of interest.
References
1. Farokhzad OC, Langer R. Nanomedicine: Developing
smarter therapeutic and diagnostic modalities. Adv
Drug Deliv Rev 2006;58(14):1456-9. doi:
10.1016/j.addr.2006.09.011
2. Roco MC. Nanotechnology: Convergence with
modern biology and medicine. Curr Opin Biotechnol
2003;14(3):337-46. doi: 10.1016/S0958-
1669(03)00068-5
| 451
Mechanisms of Nanoparticle Toxicity
Advanced Pharmaceutical Bulletin, 2015, 5(4), 447-454
3. Caruthers SD, Wickline SA, Lanza GM.
Nanotechnological applications in medicine. Curr
Opin Biotechnol 2007;18(1):26-30. doi:
10.1016/j.copbio.2007.01.006
4. Silva GA. Introduction to nanotechnology and its
applications to medicine. Surg Neurol
2004;61(3):216-20. doi:
10.1016/j.surneu.2003.09.036
5. Singh M, Singh S, Prasad S, Gambhir IS.
Nanotechnology in medicine and antibacterial effect
of silver nanoparticles. Dig J Nanomater Bios
2008;3(3):115-22.
6. Nie S, Xing Y, Kim GJ, Simons JW. Nanotechnology
applications in cancer. Annu Rev Biomed Eng
2007;9:257-88. doi:
10.1146/annurev.bioeng.9.060906.152025
7. Choi O, Hu Z. Size dependent and reactive oxygen
species related nanosilver toxicity to nitrifying
bacteria. Environ Sci Technol 2008;42(12):4583-8.
doi: 10.1021/es703238h
8. Hussain SM, Hess KL, Gearhart JM, Geiss KT,
Schlager JJ. In vitro toxicity of nanoparticles in brl 3a
rat liver cells. Toxicol In Vitro 2005;19(7):975-83.
doi: 10.1016/j.tiv.2005.06.034
9. Zoroddu M, Medici S, Ledda A, Nurchi V, Lachowicz
J, Peana M. Toxicity of nanoparticles. Current
Medicinal Chem 2014;21(33):3837-53. doi:
10.2174/0929867321666140601162314
10. Marie Curie Initial Training Network -
Environmental Chemoinformatics (ECO). Toxicity of
nanoparticles. Project report – ITN-ECO: 2012.
11. Ahamed M, Karns M, Goodson M, Rowe J, Hussain
SM, Schlager JJ, et al. DNA damage response to
different surface chemistry of silver nanoparticles in
mammalian cells. Toxicol Appl Pharmacol
2008;233(3):404-10. doi: 10.1016/j.taap.2008.09.015
12. Sharma V, Shukla RK, Saxena N, Parmar D, Das M,
Dhawan A. DNA damaging potential of zinc oxide
nanoparticles in human epidermal cells. Toxicol Lett
2009;185(3):211-8. doi: 10.1016/j.toxlet.2009.01.008
13. Wang F, Yu L, Monopoli MP, Sandin P, Mahon E,
Salvati A, et al. The biomolecular corona is retained
during nanoparticle uptake and protects the cells from
the damage induced by cationic nanoparticles until
degraded in the lysosomes. Nanomedicine
2013;9(8):1159-68. doi: 10.1016/j.nano.2013.04.010
14. Elsaesser A, Howard CV. Toxicology of
nanoparticles. Adv Drug Deliv Rev 2012;64(2):129-
37. doi: 10.1016/j.addr.2011.09.001
15. Regoli F, Giuliani ME. Oxidative pathways of
chemical toxicity and oxidative stress biomarkers in
marine organisms. Mar Environ Res 2014;93:106-17.
doi: 10.1016/j.marenvres.2013.07.006
16. Jomova K, Baros S, Valko M. Redox active metal-
induced oxidative stress in biological systems.
Transition Met Chem 2012;37(2):127-34. doi:
10.1007/s11243-012-9583-6
17. Chen H, Yoshioka H, Kim GS, Jung JE, Okami N,
Sakata H, et al. Oxidative stress in ischemic brain
damage: mechanisms of cell death and potential
molecular targets for neuroprotection. Antioxid
Redox Signal 2011;14(8):1505-17. doi:
10.1089/ars.2010.3576
18. Soenen SJ, Rivera-Gil P, Montenegro JM, Parak WJ,
De Smedt SC, Braeckmans K. Cellular toxicity of
inorganic nanoparticles: Common aspects and
guidelines for improved nanotoxicity evaluation.
Nano Today 2011;6(5):446-65. doi:
10.1016/j.nantod.2011.08.001
19. Mahmoudi M, Hofmann H, Rothen-Rutishauser B,
Petri-Fink A. Assessing the in vitro and in vivo
toxicity of superparamagnetic iron oxide
nanoparticles. Chem Rev 2012;112(4):2323-38. doi:
10.1021/cr2002596
20. Fischer J, Prosenc MH, Wolff M, Hort N, Willumeit
R, Feyerabend F. Interference of magnesium
corrosion with tetrazolium-based cytotoxicity assays.
Acta Biomater 2010;6(5):1813-23. doi:
10.1016/j.actbio.2009.10.020
21. Rabolli V, Thomassen LC, Princen C, Napierska D,
Gonzalez L, Kirsch-Volders M, et al. Influence of
size, surface area and microporosity on the in vitro
cytotoxic activity of amorphous silica nanoparticles
in different cell types. Nanotoxicology 2010;4(3):307-
18. doi: 10.3109/17435390.2010.482749
22. Kumbıçak Ü, Çavaş T, Çinkılıç N, Kumbıçak Z,
Vatan Ö, Yılmaz D. Evaluation of in vitro
cytotoxicity and genotoxicity of copper-zinc alloy
nanoparticles in human lung epithelial cells. Food
Chem Toxicol 2014;73:105-12. doi:
10.1016/j.fct.2014.07.040
23. Fotakis G, Timbrell JA. In vitro cytotoxicity assays:
Comparison of ldh, neutral red, mtt and protein assay
in hepatoma cell lines following exposure to
cadmium chloride. Toxicol Lett 2006;160(2):171-7.
doi: 10.1016/j.toxlet.2005.07.001
24. Crouch SPM, Kozlowski R, Slater KJ, Fletcher J.
The use of atp bioluminescence as a measure of cell
proliferation and cytotoxicity. J Immunol Methods
1993;160(1):81-8. doi: 10.1016/0022-
1759(93)90011-U
25. Schiewe MH, Hawk EG, Actor DI, Krahn MM. Use
of a bacterial bioluminescence assay to assess toxicity
of contaminated marine sediments. Can J Fish Aquat
Sci 1985;42(7):1244-8. doi: 10.1139/f85-154
26. Benton MJ, Malott ML, Knight SS, Cooper CM,
Benson WH. Influence of sediment composition on
apparent toxicity in a solid-phase test using
bioluminescent bacteria. Environ Toxicol Chem
1995;14(3):411-4. doi: 10.1002/etc.5620140309
27. Asare N, Instanes C, Sandberg WJ, Refsnes M,
Schwarze P, Kruszewski M, et al. Cytotoxic and
genotoxic effects of silver nanoparticles in testicular
cells. Toxicology 2012;291(1-3):65-72. doi:
10.1016/j.tox.2011.10.022
28. Korzeniewski C, Callewaert DM. An enzyme-release
assay for natural cytotoxicity. J Immunol Methods
452 | Advanced Pharmaceutical Bulletin, 2015, 5(4), 447-454
Khalili fard et al.
1983;64(3):313-20. doi: 10.1016/0022-
1759(83)90438-6
29. van Meerloo J, Kaspers GJ, Cloos J. Cell sensitivity
assays: The MTT assay. In: Cree IA, editor. Cancer
cell culture. Hatfield: Springer; 2011. P. 237-45.
30. Malich G, Markovic B, Winder C. The sensitivity
and specificity of the mts tetrazolium assay for
detecting the in vitro cytotoxicity of 20 chemicals
using human cell lines. Toxicology 1997;124(3):179-
92. doi: 10.1016/S0300-483X(97)00151-0
31. Cho WS, Duffin R, Thielbeer F, Bradley M, Megson
IL, MacNee W, et al. Zeta potential and solubility to
toxic ions as mechanisms of lung inflammation
caused by metal/metal oxide nanoparticles. Toxicol
Sci 2012;126(2):469-77. doi:
10.1016/10.1093/toxsci/kfs006
32. Donaldson K, Poland CA, Schins RP. Possible
genotoxic mechanisms of nanoparticles: Criteria for
improved test strategies. Nanotoxicology
2010;4(4):414-20. doi:
10.3109/17435390.2010.482751
33. Stern ST, Adiseshaiah PP, Crist RM. Autophagy and
lysosomal dysfunction as emerging mechanisms of
nanomaterial toxicity. Part Fibre Toxicol
2012;9(1):20. doi: 10.1186/1743-8977-9-20
34. Li Y, Zhang W, Niu J, Chen Y. Surface-coating-
dependent dissolution, aggregation, and reactive
oxygen species (ros) generation of silver
nanoparticles under different irradiation conditions.
Environ Sci Technol 2013;47(18):10293-301. doi:
10.1021/es400945v
35. Nishanth RP, Jyotsna RG, Schlager JJ, Hussain SM,
Reddanna P. Inflammatory responses of raw 264.7
macrophages upon exposure to nanoparticles: Role of
ros-nfκb signaling pathway. Nanotoxicology
2011;5(4):502-16. doi:
10.3109/17435390.2010.541604
36. Luna-Velasco A, Field JA, Cobo-Curiel A, Sierra-
Alvarez R. Inorganic nanoparticles enhance the
production of reactive oxygen species (ros) during the
autoxidation of L-3,4-dihydroxyphenylalanine (L-
dopa). Chemosphere 2011;85(1):19-25. doi:
10.1016/j.chemosphere.2011.06.053
37. Shao W, Arghya P, Yiyong M, Rodes L, Prakash S.
Carbon nanotubes for use in medicine: Potentials and
limitations. In: Suzuki S, editor. Syntheses and
Applications of Carbon Nanotubes and Their
Composites. Croatia: InTech; 2013. P. 285-311.
38. De Volder MF, Tawfick SH, Baughman RH, Hart
AJ. Carbon nanotubes: Present and future commercial
applications. Science 2013;339(6119):535-9. doi:
10.1126/science.1222453
39. O’connell MJ. Carbon nanotubes: Properties and
applications. Boca Raton: CRC Press; 2012.
40. Shvedova AA, Pietroiusti A, Fadeel B, Kagan VE.
Mechanisms of carbon nanotube-induced toxicity:
Focus on oxidative stress. Toxicol Appl Pharmacol
2012;261(2):121-33. doi: 10.1016/j.taap.2012.03.023
41. Johnston HJ, Hutchison GR, Christensen FM, Peters
S, Hankin S, Aschberger K, et al. A critical review of
the biological mechanisms underlying the in vivo and
in vitro toxicity of carbon nanotubes: The
contribution of physico-chemical characteristics.
Nanotoxicology 2010;4(2):207-46. doi:
10.3109/17435390903569639
42. Campagnolo L, Massimiani M, Palmieri G,
Bernardini R, Sacchetti C, Bergamaschi A, et al.
Biodistribution and toxicity of pegylated single wall
carbon nanotubes in pregnant mice. Part Fibre
Toxicol 2013;10(1):21. doi: 10.1186/1743-8977-10-
21
43. Clift MJ, Endes C, Vanhecke D, Wick P, Gehr P,
Schins RP, et al. A comparative study of different in
vitro lung cell culture systems to assess the most
beneficial tool for screening the potential adverse
effects of carbon nanotubes. Toxicol Sci
2014;137(1):55-64. doi: 10.1093/toxsci/kft216
44. Murphy FA, Poland CA, Duffin R, Al-Jamal KT,
Ali-Boucetta H, Nunes A, et al. Length-dependent
retention of carbon nanotubes in the pleural space of
mice initiates sustained inflammation and progressive
fibrosis on the parietal pleura. Am J Pathol
2011;178(6):2587-600. doi:
10.1016/j.ajpath.2011.02.040
45. Yin ZF, Wu L, Yang HG, Su YH. Recent progress in
biomedical applications of titanium dioxide. Phys
Chem Chem Phys 2013;15(14):4844-58. doi:
10.1039/C3CP43938K
46. Weir A, Westerhoff P, Fabricius L, Hristovski K, von
Goetz N. Titanium dioxide nanoparticles in food and
personal care products. Environ Sci Technol
2012;46(4):2242-50. doi: 10.1021/es204168d
47. Sha B, Gao W, Han Y, Wang S, Wu J, Xu F, et al.
Potential application of titanium dioxide
nanoparticles in the prevention of osteosarcoma and
chondrosarcoma recurrence. J Nanosci Nanotechnol
2013;13(2):1208-11. doi: 10.1166/jnn.2013.6081
48. Wu Q, Guo D, Du Y, Liu D, Wang D, Bi H. UVB
irradiation enhances TiO2 nanoparticle-induced
disruption of calcium homeostasis in human lens
epithelial cells. Photochem Photobiol
2014;90(6):1324-31. doi: 10.1111/php.12322
49. Pierzchala K, Lekka M, Magrez A, Kulik AJ, Forró
L, Sienkiewicz A. Photocatalytic and phototoxic
properties of TiO2-based nanofilaments: ESR and
AFM assays. Nanotoxicology 2012;6(8):813-24. doi:
10.3109/17435390.2011.625129
50. PetkoviC J, Zegura B, StevanoviC M, Drnovšek N,
UskokoviC D, Novak S, et al. DNA damage and
alterations in expression of DNA damage responsive
genes induced by TiO2 nanoparticles in human
hepatoma hepg2 cells. Nanotoxicology
2011;5(3):341-53. doi:
10.3109/17435390.2010.507316
51. Gerloff K, Fenoglio I, Carella E, Kolling J, Albrecht
C, Boots AW, et al. Distinctive toxicity of TiO2
rutile/anatase mixed phase nanoparticles on Caco-2
| 453
Mechanisms of Nanoparticle Toxicity
Advanced Pharmaceutical Bulletin, 2015, 5(4), 447-454
cells. Chem Res Toxicol 2012;25(3):646-55. doi:
10.1021/tx200334k
52. Montiel-Dávalos Al, Ventura-Gallegos JL, Alfaro-
Moreno E, Soria-Castro E, García-Latorre E,
Cabañas-Moreno JG, et al. TiO2 nanoparticles induce
dysfunction and activation of human endothelial
cells. Chem Res Toxicol 2012;25(4):920-30. doi:
10.1021/tx200551u
53. Jin C, Tang Y, Yang FG, Li XL, Xu S, Fan XY, et al.
Cellular toxicity of TiO2 nanoparticles in anatase and
rutile crystal phase. Biol Trace Elem Res 2011;141(1-
3):3-15. doi: 10.1007/s12011-010-8707-0
54. Xiong S, George S, Ji Z, Lin S, Yu H, Damoiseaux
R, et al. Size of TiO2 nanoparticles influences their
phototoxicity: An in vitro investigation. Arch Toxicol
2013;87(1):99-109. doi: 10.1007/s00204-012-0912-5
55. Ivask A, Bondarenko O, Jepihhina N, Kahru A.
Profiling of the reactive oxygen species-related
ecotoxicity of CuO, ZnO, TiO2, silver and fullerene
nanoparticles using a set of recombinant luminescent
escherichia coli strains: Differentiating the impact of
particles and solubilised metals. Anal Bioanal Chem
2010;398(2):701-16. doi: 10.1007/s00216-010-3962-
7
56. Chen EY, Garnica M, Wang YC, Mintz AJ, Chen
CS, Chin WC. A mixture of anatase and rutile TiO2
nanoparticles induces histamine secretion in mast
cells. Part Fibre Toxicol 2012;9:2. doi:
10.1186/1743-8977-9-2
57. Scherbart AM, Langer J, Bushmelev A, van Berlo D,
Haberzettl P, van Schooten FJ, et al. Contrasting
macrophage activation by fine and ultrafine titanium
dioxide particles is associated with different uptake
mechanisms. Part Fibre Toxicol 2011;8:31. doi:
10.1186/1743-8977-8-31
58. Fu J, Rong G, Deng Y. Mammalian cell cytotoxicity
and genotoxicity of metallic nanoparticles. Adv Sci
Lett 2012;5(1):294-8. doi: 10.1166/asl.2012.1946
59. Ghosh M, Chakraborty A, Mukherjee A. Cytotoxic,
genotoxic and the hemolytic effect of titanium
dioxide (TiO2) nanoparticles on human erythrocyte
and lymphocyte cells in vitro. J Appl Toxicol
2013;33(10):1097-110. doi: 10.1002/jat.2863
60. Xiong S, George S, Yu H, Damoiseaux R, France B,
Ng KW, et al. Size influences the cytotoxicity of poly
(lactic-co-glycolic acid) (PLGA) and titanium dioxide
(TiO2) nanoparticles. Arch Toxicol 2013;87(6):1075-
86. doi: 10.1007/s00204-012-0938-8
61. Osiński M, Parak WJ, Jovin TM, Yamamoto K.
Colloidal Quantum Dots for Biomedical Applications
V, SPIE International Symposium on Biomedical
Optics BiOS 2010, Vol. 7575, Paper 75750Z San
Francisco, California, 23‐25 January 2010.
62. Chen N, He Y, Su Y, Li X, Huang Q, Wang H, et al.
The cytotoxicity of cadmium-based quantum dots.
Biomaterials 2012;33(5):1238-44. doi:
10.1016/j.biomaterials.2011.10.070
63. Hoshino A, Hanada S, Yamamoto K. Toxicity of
nanocrystal quantum dots: The relevance of surface
modifications. Arch Toxicol 2011;85(7):707-20. doi:
10.1007/s00204-011-0695-0
64. Zheng X, Tian J, Weng L, Wu L, Jin Q, Zhao J, et al.
Cytotoxicity of cadmium-containing quantum dots
based on a study using a microfluidic chip.
Nanotechnology 2012;23(5):055102. doi:
10.1088/0957-4484/23/5/055102
65. Singh BR, Singh BN, Khan W, Singh HB, Naqvi
AH. ROS-mediated apoptotic cell death in prostate
cancer LNCaP cells induced by biosurfactant
stabilized CdS quantum dots. Biomaterials
2012;33(23):5753-67. doi:
10.1016/j.biomaterials.2012.04.045
66. Kauffer FA, Merlin C, Balan L, Schneider R.
Incidence of the core composition on the stability, the
ROS production and the toxicity of CdSe quantum
dots. J Hazard Mater 2014;268:246-55. doi:
10.1016/j.jhazmat.2014.01.029
67. Dykman L, Khlebtsov N. Gold nanoparticles in
biomedical applications: Recent advances and
perspectives. Chem Soc Rev 2012;41(6):2256-82. doi:
10.1039/C1CS15166E
68. Tiwari PM, Vig K, Dennis VA, Singh SR.
Functionalized gold nanoparticles and their
biomedical applications. Nanomaterials
2011;1(1):31-63. doi: 10.3390/nano1010031
69. Yeh YC, Creran B, Rotello VM. Gold nanoparticles:
Preparation, properties, and applications in
bionanotechnology. Nanoscale 2012;4(6):1871-80.
doi: 10.1039/C1NR11188D
70. Lim ZZJ, Li JEJ, Ng CT, Yung LYL, Bay BH. Gold
nanoparticles in cancer therapy. Acta Pharmacol Sin
2011;32(8):983-90. doi: 10.1038/aps.2011.82
71. Jain S, Hirst DG, O'sullivan JM. Gold nanoparticles
as novel agents for cancer therapy. Br J Radiol
2012;85(1010):101-13. doi: 10.1259/bjr/59448833
72. Heo DN, Yang DH, Moon HJ, Lee JB, Bae MS, Lee
SC, et al. Gold nanoparticles surface-functionalized
with paclitaxel drug and biotin receptor as theranostic
agents for cancer therapy. Biomaterials
2012;33(3):856-66. doi:
10.1016/j.biomaterials.2011.09.064
73. Khlebtsov N, Dykman L. Biodistribution and toxicity
of engineered gold nanoparticles: A review of in vitro
and in vivo studies. Chem Soc Rev 2011;40(3):1647-
71. doi: 10.1039/C0CS00018C
74. Taylor U, Barchanski A, Garrels W, Klein S, Kues
W, Barcikowski S, et al. Toxicity of gold
nanoparticles on somatic and reproductive cells. In:
Zahavy E, Ordentlich A, Yitzhaki S, Shafferman A,
editors. Nano-biotechnology for biomedical and
diagnostic research. New York: Springer; 2012. P.
125-33.
75. Loumaigne M, Richard A, Laverdant J, Nutarelli D,
Débarre A. Ligand-induced anisotropy of the two-
photon luminescence of spherical gold particles in
solution unraveled at the single particle level. Nano
lett 2010;10(8):2817-24. doi: 10.1021/nl100737y
454 | Advanced Pharmaceutical Bulletin, 2015, 5(4), 447-454
Khalili fard et al.
76. Arnida, Janát-Amsbury MM, Ray A, Peterson CM,
Ghandehari H. Geometry and surface characteristics
of gold nanoparticles influence their biodistribution
and uptake by macrophages. Eur J Pharm Biopharm
2011;77(3):417-23. doi: 10.1016/j.ejpb.2010.11.010
77. Pissuwan D, Niidome T, Cortie MB. The
forthcoming applications of gold nanoparticles in
drug and gene delivery systems. J Control Release
2011;149(1):65-71. doi:
10.1016/j.jconrel.2009.12.006
78. Coradeghini R, Gioria S, García CP, Nativo P,
Franchini F, Gilliland D, et al. Size-dependent
toxicity and cell interaction mechanisms of gold
nanoparticles on mouse fibroblasts. Toxicol lett
2013;217(3):205-16. doi:
10.1016/j.toxlet.2012.11.022
79. Chaloupka K, Malam Y, Seifalian AM. Nanosilver as
a new generation of nanoproduct in biomedical
applications. Trends Biotechnol 2010;28(11):580-8.
doi: 10.1016/j.tibtech.2010.07.006
80. García-Barrasa J, López-de-Luzuriaga JM, Monge
M. Silver nanoparticles: Synthesis through chemical
methods in solution and biomedical applications.
Cent Eur J Chem 2011;9(1):7-19. doi:
10.2478/s11532-010-0124-x
81. Wang Y, Newell BB, Irudayaraj J. Folic acid
protected silver nanocarriers for targeted drug
delivery. J Biomed Nanotechnol 2012;8(5):751-9.
doi: 10.1166/jbn.2012.1437
82. Zhou W, Ma Y, Yang H, Ding Y, Luo X. A label-
free biosensor based on silver nanoparticles array for
clinical detection of serum p53 in head and neck
squamous cell carcinoma. Int J Nanomedicine
2011;6(1):381-6. doi: 10.2147/IJN.S13249
83. Wang J, Song D, Wang L, Zhang H, Zhang H, Sun
Y. Design and performances of immunoassay based
on spr biosensor with au/ag alloy nanocomposites.
Sensors Actuators B: Chem 2011;157(2):547-53. doi:
10.1016/j.snb.2011.05.020
84. Mei N, Zhang Y, Chen Y, Guo X, Ding W, Ali SF, et
al. Silver nanoparticle-induced mutations and
oxidative stress in mouse lymphoma cells. Environ
Mol Mutagen 2012;53(6):409-19. doi:
10.1002/em.21698
85. Kim S, Ryu DY. Silver nanoparticle-induced
oxidative stress, genotoxicity and apoptosis in
cultured cells and animal tissues. J Appl Toxicol
2013;33(2):78-89. doi: 10.1002/jat.2792
86. Xin L, Wang J, Wu Y, Guo S, Tong J. Increased
oxidative stress and activated heat shock proteins in
human cell lines by silver nanoparticles. Hum Exp
Toxicol 2015;34(3):315-23. doi:
10.1177/0960327114538988
87. Yang X, Gondikas AP, Marinakos SM, Auffan M,
Liu J, Hsu-Kim H, et al. Mechanism of silver
nanoparticle toxicity is dependent on dissolved silver
and surface coating in caenorhabditis elegans.
Environ Sci Technol 2012;46(2):1119-27. doi:
10.1021/es202417t
88. Batchelor-McAuley C, Tschulik K, Neumann C,
Laborda E, Compton RG. Why are silver
nanoparticles more toxic than bulk silver? Towards
understanding the dissolution and toxicity of silver
nanoparticles. Int J Electrochem Sci 2014;9(3):1132-
8.
89. Gliga AR, Skoglund S, Wallinder IO, Fadeel B,
Karlsson HL. Size-dependent cytotoxicity of silver
nanoparticles in human lung cells: The role of cellular
uptake, agglomeration and ag release. Part Fibre
Toxicol 2014;11(1):11. doi: 10.1186/1743-8977-11-
11
90. Sanwlani S, Rawat K, Pal M, Bohidar HB, Verma
AK. Cellular uptake induced biotoxicity of surface-
modified cdse quantum dots. J Nanopart Res
2014;16:2382. doi: 10.1007/s11051-014-2382-6
91. Vicario-Parés U, Castañaga L, Lacave JM, Oron M,
Reip P, Berhanu D, et al. Comparative toxicity of
metal oxide nanoparticles (CuO, ZnO and TiO2) to
developing zebrafish embryos. J Nanopart Res
2014;16:2550. doi: 10.1007/s11051-014-2550-8
92. Pujalté I, Passagne I, Brouillaud B, Tréguer M,
Durand E, Ohayon-Courtès C, et al. Cytotoxicity and
oxidative stress induced by different metallic
nanoparticles on human kidney cells. Part Fibre
Toxicol 2011;8:10. doi: 10.1186/1743-8977-8-10
93. Lee YH, Cheng FY, Chiu HW, Tsai JC, Fang CY,
Chen CW, et al. Cytotoxicity, oxidative stress,
apoptosis and the autophagic effects of silver
nanoparticles in mouse embryonic fibroblasts.
Biomaterials 2014;35(16):4706-15. doi:
10.1016/j.biomaterials.2014.02.021
94. Chueh PJ, Liang RY, Lee YH, Zeng ZM, Chuang
SM. Differential cytotoxic effects of gold
nanoparticles in different mammalian cell lines. J
Hazard Mater 2014;264:303-12. doi:
10.1016/j.jhazmat.2013.11.031
95. Grabowski N, Hillaireau H, Vergnaud J, Santiago
LA, Kerdine-Romer S, Pallardy M, et al. Toxicity of
surface-modified plga nanoparticles toward lung
alveolar epithelial cells. Int J Pharm
2013;454(2):686-94. doi:
10.1016/j.ijpharm.2013.05.025